Sensus Healthcare Inc. (SRTS) exhibits 43.2% gross margins and -31.3% return on invested capital within Health Care (Medical/Dental Instruments), balanced against a 24.0x enterprise multiple and 4.8% implied options volatility.
Sustained 43.2% gross profitability converts into -37.5% operating margin and -31.3% ROIC, outpacing sector cost of capital.
ROIC: -31.3% // GM: 43.2%YoY revenue trajectory of -34.3% paired with 0.73% free cash flow yield supports self-funded R&D and capital return.
REV YOY: -34.3% // FCF YLD: 0.73%Altman Z-Score of 6.50 and Piotroski F-Score of 5/9 indicate low near-term refinancing stress.
ALTMAN Z: 6.50 // F-SCORE: 5/9Trading at 24.0x trailing P/E (— Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 24.0x // EV/EBITDA: —Options market prices a ±5.2% implied move with a 0.85 put/call ratio around $2.77 max pain.
IMPL MOVE: ±5.2% // P/C: 0.85Elevated industry capital intensity and customer concentration in Medical/Dental Instruments require continuous execution to defend -28.1% net margins.
NET MARGIN: -28.1% // D/E: 0.45x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for SRTS & activate live FRED threshold breach alerts.